Heteroaryl inhibitors of PDE4
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
21.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!